Combination of osimertinib and bevacizumab as first-line treatment for patients with metastatic EGFR-mutant lung cancers - In reply Correspondence

  

Authors:	Schoenfeld, A. J.; Yu, H. A.
Title:	Combination of osimertinib and bevacizumab as first-line treatment for patients with metastatic EGFR-mutant lung cancers - In reply
Journal Title:	JAMA Oncology
Volume:	6
Issue:	12
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2020-12-01
Start Page:	1983
Language:	English
DOI:	10.1001/jamaoncol.2020.4824
PUBMED:	33119042
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095829944&doi=10.1001%2fjamaoncol.2020.4824&partnerID=40&md5=53cdf4296dc65bd13e85a64e9a123128
Notes:	Letter -- Export Date: 4 January 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/174972